Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John DeLuca

Showing results (251-260 of 276) with videos related to

Pageof 28
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2019
Computerized neuropsychological assessment devices in multiple sclerosis: A systematic reviewCurtis M Wojcik, Meghan Beier, Kathleen Costello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Recommendations for cognitive screening and management in multiple sclerosis careRosalind Kalb, Meghan Beier, Ralph Hb Benedict, et al.
The Clinical Neuropsychologist|June 10, 2016
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS)Elizabeth S Gromisch, Vance Zemon, Roee Holtzer, et al.
BMC Neurology|May 24, 2020
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Journal of Neurology|August 20, 2020
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosisNancy D Chiaravalloti, Maria Pia Amato, Giampaolo Brichetto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2025
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trialsJeffrey A Cohen, Douglas L Arnold, John DeLuca, et al.
Journal of Neurology|November 6, 2021
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experienceAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Journal of Neurology|August 8, 2022
The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx studyAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
The Lancet. Neurology|September 22, 2023
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trialAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2021
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx studyBrian M Sandroff, Robert W Motl, Maria Pia Amato, et al.
Pageof 28

Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2019
Computerized neuropsychological assessment devices in multiple sclerosis: A systematic reviewCurtis M Wojcik, Meghan Beier, Kathleen Costello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Recommendations for cognitive screening and management in multiple sclerosis careRosalind Kalb, Meghan Beier, Ralph Hb Benedict, et al.
The Clinical Neuropsychologist|June 10, 2016
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS)Elizabeth S Gromisch, Vance Zemon, Roee Holtzer, et al.
BMC Neurology|May 24, 2020
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Journal of Neurology|August 20, 2020
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosisNancy D Chiaravalloti, Maria Pia Amato, Giampaolo Brichetto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2025
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trialsJeffrey A Cohen, Douglas L Arnold, John DeLuca, et al.
Journal of Neurology|November 6, 2021
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experienceAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Journal of Neurology|August 8, 2022
The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx studyAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
The Lancet. Neurology|September 22, 2023
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trialAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2021
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx studyBrian M Sandroff, Robert W Motl, Maria Pia Amato, et al.
Pageof 28